posted
Three Sixty, Inc. (TSXT) Announces Rockford-Montgomery Labs, Inc.Acquisition Terms
Jul 12, 2007 09:06:40 (ET)
ATHENS, GA, Jul 12, 2007 (MARKET WIRE via COMTEX) -- Three Sixty, Inc. (PINKSHEETS: TSXT), an acquisition company, entered into an Agreement on May 22, 2007 with Rockford-Montgomery Labs, Inc. ("RML"), a brand management company focused on the marketing, sales, production, and distribution of 360 OTC(R) pharmaceutical products, to purchase RML for stock. The acquisition was finalized on June 29, 2007 for 26,688,155 shares of restricted common stock, with a minimum twelve-month restriction.
The majority of RML's shareholders come from the initial seed capital; services exchanged for stock; the acquisition of the PHARB Hangover Relief formula, know-how and customer base purchased from Pharbco Marketing Group, Inc. ("PMG"); and various other investors. Services exchanged for stock include, but are not limited to, graphic design services, product packaging engineering services, film and editing services, computer services, personal service agreements, employee incentives, website design, sales, marketing and various other services utilized to run the company. Michelle Shearer, CEO of RML, states, "It was great to issue stock for services in the infant stage of RML as it allowed the maximum use of its operating capital." The shareholders of RML (and the former PMG shareholders) will receive two shares of TSXT for every one share of RML. Information is being mailed this week to all shareholders of both RML and PMG informing them of the stock transfer process. The company believes the transfer of shares will be completed within the next 30 to 60 days and will not increase the current authorized shares as these shares were taken into consideration when Three Sixty, Inc. reduced its authorized shares to 50 Million Common Shares.
This will give the company a total share structure of 50,000,000 authorized common shares of which 5,300,000 common shares in the public float and approximately 28,701,000 restricted common shares for a minimum of one year. The company has no plans to increase the authorized shares.
The total cost to TSXT is 26,688,155 of restricted common shares. The transaction accomplished three goals: 1. to provide the shareholders of RML with a fair stock transaction, 2. TSXT acquired the entire business of RML; which will increase overall shareholder value, and 3. the current shareholders of TSXT will benefit from the business RML provides, which will also create shareholder value.
"Every stockholder, the current TSXT shareholders, RML shareholders and PMG shareholders should be excited about this company. We have a lot of potential and TSXT's number one goal is to create shareholder value," stated Ms. Shearer.
Being a wholly owned subsidiary of TSXT allows RML, who has already established relationships with retailers, vendors, customers and various other business relationships, to continue as normal and be a public entity. Michelle Shearer will continue as Chief Executive Officer of Rockford-Montgomery Labs, Inc. and Three Sixty, Inc. All employees will remain under Rockford-Montgomery Labs, Inc. with the exception of Todd Weller who will be President of both companies.
This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company's limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company's projections or forward-looking statements. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Contact:
Three Sixty, Inc. Investor Relations Tel: 1-706-354-3725 Fax: 1-800-927-1593
posted
Three Sixty, Inc. (TSXT) Announces Its Current Board of Directors andOfficers
Jul 12, 2007 12:42:05 (ET)
ATHENS, GA, Jul 12, 2007 (MARKET WIRE via COMTEX) -- Three Sixty, Inc. (PINKSHEETS: TSXT) and its wholly owned subsidiary Rockford-Montgomery Labs, Inc. announced their current Board of Directors and Officers. RML is the innovator of the 360 OTC(TM) brand ( www.360otc.com ) of over-the-counter pharmaceutical products.
Chairman of the Board & Chief Executive Officer:
Michelle E. Shearer
Ms. Shearer, CPA, is the founder of Rockford-Montgomery Labs, Inc., who created the 360 OTC(TM) brand. Michelle was a Medallion Scholarship recipient from Western Michigan University where she graduated in December of 1998 with a Bachelor's degree in Business Administration in Accountancy and a Minor in French and General Business. Ms. Shearer is a Delta Zeta and has served in the capacity of President, Scholarship Chair, Faculty Relations Chair, member of the By-laws Committee and Judicial Board, and was inducted in the Order of Omega Greek Honor Society. Michelle began her career in public accounting at the regional Michigan firm of Rehmann Robson (now The Rehmann Group) in the areas of audit and tax. She moved to Deloitte & Touche LLP where she became Manager within two years and carried that title with her to PricewaterhouseCoopers LLP. Ms. Shearer has worked with Fortune 100 companies in the areas of transfer pricing, domestic and international taxation, Sarbanes-Oxley implementation and public reporting. She has prior work experience in the Property Tax and Corporate Tax departments at the Pharmacia & Upjohn Company, which is now Pfizer. She received a Pharmacia & Upjohn Special Recognition Award for being instrumental with the Internal Revenue Service to reduce a multi-state sales/use tax audit assessment by approximately $8.0 million.
Director:
Melba G. Cooper
Melba G. Cooper is Director Emerita of the University of Georgia J.W. Fanning Institute for Leadership. Melba brings to the Three Sixty, Inc., Board of Directors a wealth of experience in the area of leadership and management development. In addition to her tenure at the University of Georgia, she has served in a variety of capacities: two terms on the Georgia College and State University Foundation Board of Trustees; past president and member of the board of directors for the Georgia Adult Education Association; Kettering Foundation adjunct faculty appointment for National Issues Forums Public Policy Institutes; visiting faculty member to the University of Poznan, Poland, and University of Veracruz, Mexico; visiting faculty member to the University of Tennessee and Mississippi State University; and director of the W.K. Kellogg Foundation's Rural Revitalization Initiative for Georgia. She has participated in Harvard University's Senior Executive Program of the John F. Kennedy School of Government and the Center for Creative Leadership in Greensboro, North Carolina. Upon retiring from the University of Georgia, Melba remains active in the area of leadership and management development.
Director:
Dr. Rick A. Brewer, MD, FACEP
Dr. Brewer attended the University of Arkansas where he received a Bachelor of Sciences in Biology and a Doctor of Medicine. He has been practicing medicine for over 20 years. Dr. Brewer has served on the Board of Directors for Athens Regional Medical Center and is currently an active staff member at St. Mary's Hospital and Regional FirstCare in Athens, GA. His prior work experience at Athens Regional Medical Center was as an active staff member and an original shareholder of G.E.M.S., P.C., where he served on the Board of Directors, as an Assistant Medical Director for the Department of Emergency Medicine, Vice-President and Treasurer. Dr. Brewer's professional memberships include the American College of Emergency Physicians, Georgia College of Emergency Physicians and the Christian Medical and Dental Association. He is also a founder and Secretary/Treasurer of Smokin' Rx, Inc. Dr. Brewer brings to the Three Sixty, Inc., Board of Directors a wealth of experience in the areas of Medicine, Regulatory Guidance, Compliance, Business Acumen and entrepreneurial success.
President:
Todd Weller
Todd Weller, who has spent 7 years at Sprint NEXTEL as Vice-President of Business Development, Sports Sponsorships, Area Vice-President and General Manager, has devised and implemented solutions to a diverse range of business, technology, sales and marketing challenges in both corporate and entrepreneurial environments. Mr. Weller is skilled in strategic planning, account management, executive relationships, budgeting, profit & loss management and is successful in launching and resurrecting stagnant sales & business operations.
ABOUT THREE SIXTY, INC:
Three Sixty, Inc. is an acquisition company of branded healthcare and food products. The Company targets niche market segments of nationally distributed brands in their respective categories across food, drug, convenience stores and mass merchandisers.
Rockford-Montgomery Labs, Inc., a wholly owned subsidiary of Three Sixty, Inc., 360 OTC(TM) product line includes 360 OTC(TM) Pain Relief and 360 OTC(TM) Alertness Aid which are available now in 12,121 CVS/Pharmacy, Walgreens and Meijer stores nationally. The 360 OTC(TM) Hangover Relief and Hangover Relief Lite products will be available to all of its current retailers and at TARGET in August 2007.
For more information, please visit the Company's website: www.360OTC.com .
This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company's limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company's projections or forward-looking statements. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Contact:
Three Sixty, Inc. Investor Relations Tel: 1-706-354-3725 Fax: 1-800-927-1593
posted
Great to see that they know how to blow smoke up our arses!!!! Now lets see some real action and get this value where it belongs.....$1.10 and higher!!!
-------------------- Help me....I am drowning in stupidity!!
IP: Logged |
posted
I've been in this one for a while and I expect it to do well. Hopefully i'm not being duped but I have a good feeling about this one. GL
IP: Logged |
posted
Related Quotes Sym. Price Chg. TSXT Trade News 0.24 -0.09 Three Sixty, Inc. (TSXT) Announces Accelerated Distribution Plan
Jul 17, 2007 14:43:31 (ET)
ATHENS, GA, Jul 17, 2007 (MARKET WIRE via COMTEX) -- Three Sixty, Inc. (PINKSHEETS: TSXT) announced the June 29, 2007 completion of the purchase of its wholly owned subsidiary, Rockford-Montgomery Labs, Inc. ("RML"). Included in the purchase was the established PHARB(R) Hangover Relief formula, know-how and customer base acquired from Pharbco Marketing Group, Inc. ("PMG").
RML is pleased to announce that it has decided to place the PHARB(R) logo on the front of its new packaging along with 360 OTC(TM) and introduce the launch of the new product as 360 OTC(TM) Hangover Relief "Powered by PHARB." This decision was based on the popularity of the PHARB(R) brand name and the previous distribution of the product. The value of PHARB(R) stems back 10 years to its inception in 1997. The Hangover Relief product was available in over 55,000 stores nationally.
Michelle Shearer, Three Sixty's CEO, stated, "This will allow us to immediately tap into the same national distribution network that PHARB(R) utilized and will give the company immediate access into the 145,119 convenience stores nationally that represent sales of in-store merchandise of $163.6 billion for 2006. By leveraging the 360 OTC(TM) Hangover Relief 'Powered by PHARB' at mass convenience stores and by securing the 'check-out' stand position in these stores, we will see an increase in profits and a substantial increase in revenue. Our twelve-month projections of $32,500,000 to 35,000,000 accounted for having our 2-pack (trial pack) in two major convenience store chains by the end of this year. By changing our distribution strategy to integrate with the PHARB(R) brand products, this will bring our projections to a minimum of 10 major chain stores nationally, accelerating the growth of our business."
Three Sixty, Inc. is an acquisition company. Rockford-Montgomery Labs, Inc. is a brand management company focused on the marketing, sales, and production of the 360 OTC(TM) brand.
This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company's limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company's projections or forward-looking statements. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Contact:
Three Sixty, Inc. Investor Relations Tel: 1-706-354-3725 Fax: 1-800-927-1593
posted
Bought this awhile back at .14 sold it at .53 and .62 Made a nice bit of change.. I am out of it now. Hope you all make a nice little profit as wel....
IP: Logged |
posted
Three Sixty, Inc. (TSXT) Targets US Military Post Exchanges With Its360OTC Branded Products
Jul 18, 2007 08:59:31 (ET)
ATHENS, GA, Jul 18, 2007 (MARKET WIRE via COMTEX) -- Three Sixty, Inc. (PINKSHEETS: TSXT), an OTC Pharmaceutical holding company, announced today that Rockford-Montgomery Labs, Inc. (a wholly owned subsidiary of Three Sixty, Inc.), a brand management & distribution company has now focused on their planned marketing and sales efforts towards the 3,100 US Military's PX (Post Exchange) and BX (Base Exchanges) at US Army and Air Force bases in 30 countries (including locations in Iraq), 49 US states, and five US territories.
"We are extremely excited about marketing and creating the availability of our products to our troops. We have been working diligently on this relationship with the military since late last year and we are finally at a point where we can justify increasing manufacturing and the logistics to meet the anticipated increase in business," said Michelle Shearer, CEO of Three Sixty, Inc.
Ms. Shearer also stated, "We have spent the past three months ramping-up for a major product placement of this magnitude along with all of our other retailers that carry our products, including the yet to be released hangover relief product for all of our national accounts, including TARGET Stores, CVS, Walgreens, Meijer and the convenience store consortium (previously announced) along with the other mass merchants getting involved. The demands and challenges have been steep, we are confident the decisions and direction our management team has taken will expand our business ahead of schedule and appropriately while producing the projected financial results or better. We are now confident that all of our manufacturing, packaging, warehouse and customer service partners are in place and have the capacity to meet our current plan to supply our 360 OTC(TM) branded products to over 70,000 retail locations within the next six months."
Michelle Shearer CEO also stated that, "The company has created and welcomes all to visit the newly created company **** at www.tsxtstock.com as it is the company's intent to provide as much information to the public as possible."
This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company's limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company's projections or forward-looking statements. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Contact:
Three Sixty, Inc. Investor Relations Tel: 1-706-354-3725 Fax: 1-800-927-1593 CEO ****: www.tsxtstock.com
posted
Three Sixty, Inc. Outlines the Company's Current Share Structure andIts Plans for Its Capitalization Going Forward
Jul 24, 2007 10:46:18 (ET)
ATHENS, GA, Jul 24, 2007 (MARKET WIRE via COMTEX) -- Three Sixty, Inc. (PINKSHEETS: TSXT), a holding company, announced today its strategy regarding the company's capitalization going forward.
The company currently has a share structure of 50 million common shares authorized and 20 million preferred shares authorized. The company's plans as previously announced describes a payout of 26,688,155 million restricted common shares for the acquisition of Rockford-Montgomery Labs with a public float of approximately 5.3 million shares.
The company plans to raise the balance of its previously announced 13.5 million dollars through private placements without increasing its authorized common shares. The private placements will utilize the balance of the yet to be issued common shares in its treasury and will be priced at $1.00 per share. The shares will be restricted and will not affect the current public float.
"We are extremely committed to creating shareholder value; we believe this action will put a proper valuation on our company by keeping the public float at its current level while raising the company's required growth capital through private placements of restricted common shares. We have strong interest in the purchase of these private placement shares from accredited investors at the $1.00 per share price," said Michelle Shearer, CEO of Three Sixty, Inc.
Michelle Shearer, CEO, also stated that, "The company does not intend to increase the shares in the public float, we also intend on becoming a fully reporting company, and that these actions are being taken to improve our market cap and price per share as we position the company to move to a reporting exchange. The company is also working on its Audited Financial Statements."
This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company's limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company's projections or forward-looking statements. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Contact:
Three Sixty, Inc. Investor Relations Tel: 1-706-354-3725 Fax: 1-800-927-1593 CEO ****: www.tsxtstock.com
posted
Related Quotes Sym. Price Chg. TSXT Trade News 0.2 -0.04 Rockford-Montgomery Labs, Inc. Completes Manufacturing of Its 360OTC(TM) Hangover Relief(TM) and Hangover Relief(TM) Lite
Aug 21, 2007 08:18:47 (ET)
ATHENS, GA, Aug 21, 2007 (MARKET WIRE via COMTEX) -- Three Sixty, Inc., (PINKSHEETS: TSXT) announces today that its wholly owned subsidiary, Rockford-Montgomery Labs, Inc. (RML), has completed the inaugural manufacturing run of its Food and Drug Administration (FDA) over-the-counter (OTC) approved caplets: 360 OTC(TM) Hangover Relief(TM) and 360 OTC(TM) Hangover Relief(TM) Lite.
"We have anxiously awaited the completion of our two proprietary drugs since January 2007. The company has missed several anticipated ship dates for the 360 OTC(TM) Hangover Relief(TM) and Hangover Relief(TM) Lite products due to regulatory compliance procedures, increased stability testing and analysis set forth by the FDA and our manufacturer. The company will shift its marketing efforts to sampling and television for the Hangover Relief products, which will create immediate awareness of the 360 OTC(TM) brand," said Michelle Shearer, CEO of Three Sixty, Inc.
The company has evaluated its marketing program in detail and has decided to invest its marketing dollars into the Hangover Relief products for the remainder of 2007, to include:
1. A new 360 OTC(TM) Hangover Relief(TM) paint scheme on the #36 NASCAR Nextel Cup Car, accompanied by sampling during events. 2. An aggressive television campaign to be aired during the fourth quarter of 2007. The commercials will have specific emphasis around each of the Holidays, targeted to the youth market. 3. A sampling campaign at key events and venues during the Holidays, including Halloween, Thanksgiving, Christmas and New Years Eve. 4. A major college sampling campaign accompanied by print advertisement in college newspapers, which will target the top 1,200 college campuses in the US.
The Hangover Relief products have been well received by retailers and our marketing plan for the fourth quarter will generate additional brand awareness to our core market. The company looks forward to the next stage of the business and implementation of its new marketing strategies.
Rockford-Montgomery Labs, Inc. is a Federal Drug Administration registered drug company (#24432) incorporated in June of 2006 focused on the marketing, sales, production, and distribution of 360 OTC(TM) brand pharmaceuticals. Rockford-Montgomery has developed the brand 360 OTC(TM) and has acquired a proprietary formula for the only FDA over-the-counter approved hangover relief medicine.
Three Sixty, Inc. is an acquisition company of branded healthcare and food products. The company targets niche market segments of nationally distributed brands in its respective categories across food, drug, dollar, warehouse, convenience stores and mass merchandisers.
360 OTC(TM) products include 360 OTC(TM) Pain Relief and 360 OTC(TM) Ignite (an alertness-aid), which are available now in approximately 12,121 CVS/pharmacy, Walgreens and Meijer stores nationally.
For more information, please visit the company's website: www.360OTC.com .
This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company's limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company's projections or forward-looking statements. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Contact:
Three Sixty, Inc. Investor Relations Tel: 1-706-354-3725 Fax: 1-800-927-1593
SOURCE: Three Sixty, Inc.
-------------------- LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT!
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Eek!]](eek.gif)
